Bath & Body Works Shares Surge 25% Following Q3 Beat

UBS analysts increased their price target for Bath & Body Works (NYSE:BBWI) to $52 from $46 while keeping their Neutral rating unchanged. The analysts noted that Bath & Body Works' modest guidance for fiscal 2024 sales growth indicates a slower-than-expected recovery to pre-pandemic sales growth rates. This adjustment dampens confidence in the company's long-term revenue projections and suggests a slim chance of its price-to-earnings ratio improving.

Moreover, the company's forecast hints at a return to positive sales growth in the second half of the year, introducing additional risk. Investor discussions reveal expectations of surpassing the company's fiscal year 2024 earnings per share guidance of $3.00-$3.35, with projections leaning towards $3.50-$3.80. Consequently, even if sales growth accelerates as anticipated in the latter half, the stock may not significantly benefit since this outcome seems already anticipated.

Bath & Body Works (NYSE:BBWI) released its second-quarter results, which surpassed expectations. However, a less favorable outlook for the company's performance than initially anticipated caused a slight decline in shares pre-market today.

The company's adjusted earnings per share (EPS) of 40 cents came in better than the Street estimate of 33 cents. While revenue experienced a 3.6% decrease year-over-year, amounting to $1.56 billion, this figure aligns with what analysts had predicted.

For the current quarter, BBWI's projected EPS to fall within the range of 30 cents to 40 cents, slightly below the Street estimate of 38 cents. The company anticipates a drop in net sales of 2.5%-4.0% year-over-year.

Regarding its outlook for the full 2024 year, Bath & Body Works predicts an adjusted EPS between $2.80 and $3.10, compared to the consensus projection of $3.10. The company expects a decline in net sales of 1.5% to 3.5% year-over-year.

Bath & Body Works, Inc. (NYSE:BBWI) shares closed more than 6% lower on Thursday following the company’s reported Q1 results. While both the EPS and revenue of $0.64/$1.45 billion came in better than the consensus estimates of $0.50/$1.38 billion, 2022 guidance was cut. The company now expects Q2 diluted EPS of $0.60-$0.65. For the full 2022-year, diluted EPS is expected to be in the range of $3.80-$4.15, down from the previous $4.30-$4.70.

Analysts at Deutsche Bank said they were surprised to see the announcement of incremental investments in an environment that includes inflationary pressure, a potential slowdown in consumer spending, and increasing promotional levels.

BBWI outlined incremental investments this year including an extra $25 million to establish separate IT capabilities, $50M million due to the acceleration of the loyalty program, and "additional SG&A costs related to our CEO transition, including severance and retention for key talent and other associated expenses."

The company also called out a $225-$250 million inflation impact for the year which compares with $150-$175 million included in the prior guidance.